JAAD-D-20-00839R2 Comparative tolerability and efficacy of daylight, conventional, and combination aminolevulinic-acid-photodynamic therapy for treatment of actinic keratosis
Published: 13 January 2021| Version 1 | DOI: 10.17632/rccd7rb8yp.1
Contributors:
Lauren Crow,
Sarah Arron
Description
Supplemental figures, materials, and methods for the randomized controlled trial "Comparative tolerability and efficacy of daylight, conventional, and combination aminolevulinic-acid-photodynamic therapy for treatment of actinic keratosis" published in the Journal of the American Academy of Dermatology. ClinicalTrials.gov Identifier: NCT03322293
Files
Institutions
University of California San Francisco
Categories
Skin Cancer, Photodynamic Therapy, Skin Cancer Prevention, Actinic Keratosis, Non-Melanoma Skin Cancer